Dramin Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

dramin

takeda pharma ltda. - dimenidrinato - antiemeticos e antinauseantes

NAUSICALM B6 Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

nausicalm b6

uniÃo quÍmica farmacÊutica nacional s/a - cloridrato de piridoxina, dimenidrinato - antiemeticos e antinauseantes

NAUSILON B6 Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

nausilon b6

cifarma cientÍfica farmacÊutica ltda - dimenidrinato, cloridrato de piridoxina - antiemeticos e antinauseantes

Xospata União Europeia - português - EMA (European Medicines Agency)

xospata

astellas pharma europe b.v. - gilteritinib fumarate - leucemia, mieloide, aguda - agentes antineoplásicos - xospata é indicado como monoterapia para o tratamento de pacientes adultos que têm recidivado ou refratário leucemia mieloide aguda (lma) com uma mutação flt3.

Neofordex União Europeia - português - EMA (European Medicines Agency)

neofordex

theravia - dexametasona - mieloma múltiplo - corticosteróides para uso sistêmico - tratamento do mieloma múltiplo.

UNI-CARBAMAZ Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

uni-carbamaz

uniÃo quÍmica farmacÊutica nacional s/a - carbamazepina - anticonvulsivantes

Ertapenem SUN União Europeia - português - EMA (European Medicines Agency)

ertapenem sun

sun pharmaceutical industries (europe) b.v. - ertapenem de sódio - infecções bacterianas - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 e 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. deve ser tido em consideração a orientação oficial sobre o uso apropriado de agentes antibacterianos..

Teriparatide Sun União Europeia - português - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostase de cálcio - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Sitagliptin / Metformin hydrochloride Sun União Europeia - português - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas em diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triplo terapia de combinação), como adjuvante da dieta e exercício em pacientes inadequadamente controlados em sua máxima tolerada, a dose de metformina e uma sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.